Clinical correlations with EGFR circulating tumor DNA testing in all-stage lung adenocarcinoma.

Pimpin Incharoen,Artit Jinawath,Lalida Arsa,Kaettipong Kamprerasart,Narumol Trachu,Nanamon Monnamo,Khantong Khiewngam,Dittapol Muntham,Phichai Chansriwong,Ekaphop Sirachainan,Thanyanan Reungwetwattana

Cancer biomarkers : section A of Disease markers（2023）

引用 0|浏览5

暂无评分

摘要

Our results affirm the use of ctDNA testing in advanced-stage and recurrent NSCLC. Further studies on osimertinib as early-line therapy, clinical correlates and the utility of plasma-based testing in early-stage NSCLC are warranted.

查看译文

关键词

Circulating tumor DNA,mutation,osimertinib,pulmonary adenocarcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要